Carcinoid Heart Disease With Hypoxemia
- PMID: 38623541
- PMCID: PMC11016935
- DOI: 10.1016/j.jaccas.2024.102335
Carcinoid Heart Disease With Hypoxemia
Abstract
Patent foramen ovale (PFO) complicated with carcinoid heart disease (CHD) can cause severe hypoxia and worsening clinical conditions. We report the case of a patient with CHD in poor general condition with multiple severe valve regurgitations and PFO, who underwent successful percutaneous closure of the PFO.
Keywords: carcinoid heart disease; patent foramen ovale.
© 2024 The Authors.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Davar J., Connolly H.M., Caplin M.E., et al. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017;69:1288–1304. - PubMed
-
- Mansencal N., Mitry E., Pillière R., et al. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease. Am J Cardiol. 2008;101:1035–1038. - PubMed
-
- Douglas S., Oelofse T., Shah T., et al. Patent foramen ovale in carcinoid heart disease: the potential role for and risks of percutaneous closure prior to cardiothoracic surgery. J Neuroendocrinol. 2023;35 - PubMed
-
- Mottram P.M., McGaw D.J., Meredith I.T., et al. Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease. Eur J Echocardiogr. 2008;9:47–49. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
